HnRNPK is also identified as an oncogene and is associated with prognostic survival in various types of malignancies, but recently hnRNPK is identified as a tumor suppressor in hematologic malignancies, due to its regulation of the p53/p21 signaling pathway activation (12). The gene discussed is HNRNPK; the disease is neoplasm.